Boehringer Ingelheim is looking for a skilled to lead the launch and commercialization of Survodutide, transforming the future of obesity and metabolic health. This opportunity entails shaping brand strategy for a pre-launch asset, with responsibilities including developing customer plans, defining value propositions, and ensuring regulatory compliance.
The ideal candidate should possess over five years in pharmaceutical brand management and a strong record of success in pre-launch or launch settings. Join us to make a significant impact on patient outcomes and lead a high-performing brand team.
#J-18808-Ljbffr
📌 Metabolic Health Brand Lead - Launch & Growth (City of Sydney)
🏢 Boehringer Ingelheim
📍 City of Sydney
Reply to this offer
Impress this employer describing Your skills and abilities, fill out the form below and leave Your personal touch in the presentation letter.